Rarestep is a telemedicine company that focuses on providing specialized medical care for rare diseases. They have developed a digital platform that connects patients with rare diseases to a network of expert physicians and facilitates remote consultations and treatment options, improving accessibility and quality of care for rare disease patients.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
05/22/2023 | Series C | $148.31MM | $xx.xx | $448.59MM | Elephant | |
Price per Share
$xx.xx
Shares Outstanding
23,669,568
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Elephant
|
||||||
10/30/2020 | Series B | $21.52MM | $xx.xx | $79.17MM | Elephant | |
Price per Share
$xx.xx
Shares Outstanding
12,753,450
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Elephant
|
||||||
03/15/2019 | Series A | $457,074.51 | $xx.xx | $25.36MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,763,200
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/15/2019 | Series A-1 | $3.49MM | $xx.xx | $25.36MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
4,601,750
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
5.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|